ELI LILLY & CO (LLY) Stock Fundamental Analysis

NYSE:LLY • US5324571083

1028.83 USD
-13.32 (-1.28%)
At close: Feb 25, 2026
1031.99 USD
+3.16 (+0.31%)
Pre-Market: 2/26/2026, 4:56:14 AM
Fundamental Rating

7

Taking everything into account, LLY scores 7 out of 10 in our fundamental rating. LLY was compared to 192 industry peers in the Pharmaceuticals industry. LLY scores excellent on profitability, but there are some minor concerns on its financial health. LLY is growing strongly while it is still valued neutral. This is a good combination! Finally LLY also has an excellent dividend rating. These ratings would make LLY suitable for dividend and growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year LLY was profitable.
  • In the past year LLY had a positive cash flow from operations.
  • Each year in the past 5 years LLY has been profitable.
  • Of the past 5 years LLY 4 years had a positive operating cash flow.
LLY Yearly Net Income VS EBIT VS OCF VS FCFLLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B

1.2 Ratios

  • LLY has a better Return On Assets (16.02%) than 95.83% of its industry peers.
  • The Return On Equity of LLY (77.38%) is better than 99.48% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 28.89%, LLY belongs to the top of the industry, outperforming 97.92% of the companies in the same industry.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.89%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LLY Yearly ROA, ROE, ROICLLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • LLY's Profit Margin of 30.99% is amongst the best of the industry. LLY outperforms 94.79% of its industry peers.
  • LLY's Profit Margin has improved in the last couple of years.
  • LLY has a Operating Margin of 44.41%. This is amongst the best in the industry. LLY outperforms 98.44% of its industry peers.
  • LLY's Operating Margin has improved in the last couple of years.
  • LLY has a Gross Margin of 83.03%. This is amongst the best in the industry. LLY outperforms 87.50% of its industry peers.
  • In the last couple of years the Gross Margin of LLY has remained more or less at the same level.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
LLY Yearly Profit, Operating, Gross MarginsLLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • LLY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • LLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LLY Yearly Shares OutstandingLLY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LLY Yearly Total Debt VS Total AssetsLLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • LLY has an Altman-Z score of 8.18. This indicates that LLY is financially healthy and has little risk of bankruptcy at the moment.
  • LLY has a better Altman-Z score (8.18) than 82.29% of its industry peers.
  • LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as LLY would need 6.60 years to pay back of all of its debts.
  • LLY has a better Debt to FCF ratio (6.60) than 82.29% of its industry peers.
  • A Debt/Equity ratio of 1.72 is on the high side and indicates that LLY has dependencies on debt financing.
  • LLY has a Debt to Equity ratio of 1.72. This is in the lower half of the industry: LLY underperforms 76.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.18
ROIC/WACC3.16
WACC9.14%
LLY Yearly LT Debt VS Equity VS FCFLLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • LLY has a Current Ratio of 1.55. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • LLY has a Current ratio of 1.55. This is in the lower half of the industry: LLY underperforms 70.31% of its industry peers.
  • A Quick Ratio of 1.24 indicates that LLY should not have too much problems paying its short term obligations.
  • LLY has a worse Quick ratio (1.24) than 70.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
LLY Yearly Current Assets VS Current LiabilitesLLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

9

3. Growth

3.1 Past

  • LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.23%, which is quite impressive.
  • LLY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.01% yearly.
  • LLY shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.70%.
  • Measured over the past years, LLY shows a very strong growth in Revenue. The Revenue has been growing by 21.58% on average per year.
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.61% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, LLY will show a quite strong growth in Revenue. The Revenue will grow by 14.73% on average per year.
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y20.61%
Revenue Next Year28.68%
Revenue Next 2Y22.49%
Revenue Next 3Y19.27%
Revenue Next 5Y14.73%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LLY Yearly Revenue VS EstimatesLLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
LLY Yearly EPS VS EstimatesLLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 42.50, which means the current valuation is very expensive for LLY.
  • LLY's Price/Earnings ratio is a bit cheaper when compared to the industry. LLY is cheaper than 77.60% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of LLY to the average of the S&P500 Index (27.05), we can say LLY is valued expensively.
  • Based on the Price/Forward Earnings ratio of 30.65, the valuation of LLY can be described as expensive.
  • Based on the Price/Forward Earnings ratio, LLY is valued a bit cheaper than the industry average as 72.92% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 28.03. LLY is around the same levels.
Industry RankSector Rank
PE 42.5
Fwd PE 30.65
LLY Price Earnings VS Forward Price EarningsLLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • LLY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LLY is cheaper than 78.65% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, LLY is valued a bit cheaper than 75.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 151.11
EV/EBITDA 35.53
LLY Per share dataLLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of LLY may justify a higher PE ratio.
  • LLY's earnings are expected to grow with 23.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.1
PEG (5Y)1.7
EPS Next 2Y31.04%
EPS Next 3Y23.44%

7

5. Dividend

5.1 Amount

  • LLY has a yearly dividend return of 0.68%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.07, LLY pays a better dividend. On top of this LLY pays more dividend than 89.58% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, LLY's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • On average, the dividend of LLY grows each year by 15.59%, which is quite nice.
  • LLY has paid a dividend for at least 10 years, which is a reliable track record.
  • LLY has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)15.59%
Div Incr Years10
Div Non Decr Years34
LLY Yearly Dividends per shareLLY Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • LLY pays out 28.28% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.28%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
LLY Yearly Income VS Free CF VS DividendLLY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B
LLY Dividend Payout.LLY Dividend Payout, showing the Payout Ratio.LLY Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

NYSE:LLY (2/25/2026, 10:41:12 PM)

Premarket: 1031.99 +3.16 (+0.31%)

1028.83

-13.32 (-1.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)04-30
Inst Owners83.09%
Inst Owner Change1.99%
Ins Owners0.16%
Ins Owner Change-3.9%
Market Cap972.64B
Revenue(TTM)65.18B
Net Income(TTM)18.41B
Analysts80.54
Price Target1164.09 (13.15%)
Short Float %0.74%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend4.93
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years10
Div Non Decr Years34
Ex-Date02-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)3.03%
PT rev (3m)14.02%
EPS NQ rev (1m)-5.48%
EPS NQ rev (3m)-4.39%
EPS NY rev (1m)1.32%
EPS NY rev (3m)7.96%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)2.13%
Revenue NY rev (1m)6.1%
Revenue NY rev (3m)10.67%
Valuation
Industry RankSector Rank
PE 42.5
Fwd PE 30.65
P/S 16.37
P/FCF 151.11
P/OCF 60.55
P/B 40.88
P/tB 84.96
EV/EBITDA 35.53
EPS(TTM)24.21
EY2.35%
EPS(NY)33.56
Fwd EY3.26%
FCF(TTM)6.81
FCFY0.66%
OCF(TTM)16.99
OCFY1.65%
SpS62.85
BVpS25.17
TBVpS12.11
PEG (NY)1.1
PEG (5Y)1.7
Graham Number117.09
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.89%
ROICexc 33.3%
ROICexgc 41.12%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.18
F-Score7
WACC9.14%
ROIC/WACC3.16
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y20.61%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%
Revenue Next Year28.68%
Revenue Next 2Y22.49%
Revenue Next 3Y19.27%
Revenue Next 5Y14.73%
EBIT growth 1Y82.81%
EBIT growth 3Y53.07%
EBIT growth 5Y34.09%
EBIT Next Year43.42%
EBIT Next 3Y24.82%
EBIT Next 5Y21.25%
FCF growth 1Y382.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y166.27%
OCF growth 3YN/A
OCF growth 5YN/A

ELI LILLY & CO / LLY FAQ

Can you provide the ChartMill fundamental rating for ELI LILLY & CO?

ChartMill assigns a fundamental rating of 7 / 10 to LLY.


What is the valuation status of ELI LILLY & CO (LLY) stock?

ChartMill assigns a valuation rating of 5 / 10 to ELI LILLY & CO (LLY). This can be considered as Fairly Valued.


What is the profitability of LLY stock?

ELI LILLY & CO (LLY) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for LLY stock?

The Price/Earnings (PE) ratio for ELI LILLY & CO (LLY) is 42.5 and the Price/Book (PB) ratio is 40.88.


What is the earnings growth outlook for ELI LILLY & CO?

The Earnings per Share (EPS) of ELI LILLY & CO (LLY) is expected to grow by 38.64% in the next year.